Cargando…

PSA and Beyond: The Past, Present, and Future of Investigative Biomarkers for Prostate Cancer

The discovery of prostate-specific antigen (PSA) as a biomarker represented a major discovery in the early diagnosis and monitoring of prostate cancer. However, the use of PSA is limited by the lack of specificity and an inability to differentiate indolent from life-threatening disease reliably at t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tosoian, Jeffrey, Loeb, Stacy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: TheScientificWorldJOURNAL 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763794/
https://www.ncbi.nlm.nih.gov/pubmed/20890581
http://dx.doi.org/10.1100/tsw.2010.182